切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - CK1 - Calcium-Activated Potassium (KCa) Channels - Sigma Receptors - Vitamin D receptors (VDRs)

12件产品中的 1-10

页面
每页
清除全部
  1. Rimcazole dihydrochloride
    B6765 Rimcazole dihydrochloride
    Target: Sigma Receptors
    Summary: σ受体拮抗剂
      insoluble in H2O
  2. PRE-084 hydrochloride
    B6364 PRE-084 hydrochloride
     1 Citation
    Target: Sigma Receptors
    Summary: σ1受体激动剂
      ≥17.3 mg/mL
      insoluble in H2O
  3. Dequalinium Chloride
    B2191 Dequalinium Chloride
    中文名: 地喹氯铵
    Target: PKC|Calcium-Activated Potassium (KCa) Channels
    Summary: PKC抑制剂
      insoluble in DMSO
      insoluble in H2O
  4. Calcifediol
    B2140 Calcifediol
    中文名: 骨化二醇
    Target: Vitamin D receptors (VDRs)
    Summary: 维生素D3的主要循环形式
      ≥13.65 mg/mL
      insoluble in H2O
  5. Doxercalciferol
    B2091 Doxercalciferol
     1 Citation
    中文名: 度骨化醇
    Target: Vitamin D receptors (VDRs)
    Summary: 维生素D受体激活剂
      ≥11.5 mg/mL
      insoluble in H2O
  6. Lithocholic Acid
    A8463 Lithocholic Acid
    中文名: 石胆酸
    Target: Farnesoid X receptors (FXRs)|Vitamin D receptors (VDRs)|Pregnane X receptor(PXR)
    Summary: 维生素D受体PXR和FXR的激活剂
      ≥12.95 mg/mL
      insoluble in H2O
  7. Zonisamide
    A5354 Zonisamide
    中文名: 唑尼沙胺
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) Channels
    Summary: 抗惊厥和机械效应的抗癫痫药
      ≥8.35 mg/mL
      insoluble in H2O
  8. TRAM-34
    A1888 TRAM-34
    Target: Calcium-Activated Potassium (KCa) Channels
    Summary: KCa3.1阻断剂
      ≥17.25 mg/mL
      insoluble in H2O
  9. PF-670462
    A3719 PF-670462
    Target: CK1
    Summary: CK1 ε/δ抑制剂
      ≥20.5 mg/mL
      ≥94 mg/mL
  10. Ercalcitriol
    A3396 Ercalcitriol
    Target: Vitamin D receptors (VDRs)
    Summary: 维生素D2的活性代谢物
      Soluble in ethanol

12件产品中的 1-10

页面
每页